NCT00216567View on ClinicalTrials.gov

Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

February 28, 2006

Conditions
Epilepsy, Rolandic
Interventions
DRUG

topamax

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT00216567 - Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy | Biotech Hunter | Biotech Hunter